Aspir 81 Prices, Coupons and Patient Assistance Programs
Aspir 81 (aspirin) is a member of the platelet aggregation inhibitors drug class and is commonly used for Angina, Angina Pectoris Prophylaxis, Heart Attack, and others.
Aspir 81 Prices
This Aspir 81 price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Aspir 81 oral delayed release tablet 81 mg is around $9 for a supply of 120 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
A generic version of Aspir 81 is available, see aspirin prices.
Oral Delayed Release Tablet
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount CardPrint Now
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Aspir 81 Coupons and Rebates
Aspir 81 offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Patient Assistance Programs for Aspir 81
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
More about Aspir 81 (aspirin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Compare Alternatives
- En Español
- Drug class: platelet aggregation inhibitors
- FDA Alerts (2)